Skip to main content

News Archive

News Archive - School of Medicine

Study Finds Complete Symptom Resolution Reduces Risk of Depression Recurrence

October 27, 2015

People who have had an episode of major depression are at high risk for having another episode. Now, researchers at University of California, San Diego School of Medicine have found that the risk of recurrence is significantly lower for people with complete, rather than partial depressive symptom resolution.

NIH Grant Awards $2 Million for Research into Privacy and Personal Health Information

October 22, 2015

The National Human Genome Research Institute, a division of the National Institutes of Health (NIH), has awarded $2 million to a UC San Diego team led by Dr. Cinnamon Bloss to research individual conceptions of privacy related to emerging health big data technologies.

Spotting the Earliest Signs of Type 1 Diabetic Kidney Disease

October 22, 2015

In an effort to pinpoint the earliest signs of diabetic kidney disease, researchers at University of California, San Diego School of Medicine are leading a multi-institutional international effort dedicated to finding a new breed of disease indicators.

Actual Reality Beckons at Conference on Future of Virtual Reality

October 21, 2015

Virtual reality has become a lightning rod, with opinions split on the substance and relevance of its future applications. UC San Diego’s recent “Future of Virtual Reality” conference demonstrated that this technology has far-reaching potential—not only in the realm of gaming, but in fields like archaeology and medicine as well.

Two Lefts Make It Right: Cardiac Experts Find Novel Approach to Treat Heart Failure

October 20, 2015

A teenage girl faced with sudden rapid heart deterioration, a man in the prime years of his life suffering from debilitating heart failure and a former NFL athlete crippled by end-stage heart failure were all successfully treated with a surgical approach pioneered by cardiac experts at University of California, San Diego School of Medicine.

Three UC San Diego Researchers Elected to National Academy of Medicine

October 19, 2015

The National Academy of Medicine (NAM) announced today the election of three new members from University of California, San Diego School of Medicine: Napoleone Ferrara, MD; Christopher K. Glass, MD, PhD; and Roberto Malinow, MD, PhD. Election to NAM is considered among the highest honors in the fields of health and medicine.

UC San Diego Named Among Nation’s Most Ethnically Diverse Colleges

October 15, 2015

The University of California, San Diego has been named the 11th most ethnically diverse college in the nation, according to a new report. Best College Reviews, a ranking service for American colleges and universities, recently released a list of the top 50 ethnically diverse schools.  Statistics and definitions of race/ethnicity for the list were gathered from the National Center for Education Statistics, Diverse Issues in Higher Education and school websites. According to the report, UC San Diego looks at diversity as an opportunity for education.

Tri-City Healthcare District and UC San Diego Health Enter into an Exclusive Affiliation

October 14, 2015

UC San Diego Health and Tri-City Healthcare District announced today that they have entered into an exclusive, long-term strategic affiliation designed to enhance the delivery of high quality health care to patients in North San Diego County.

Deadly Bacteria Stiff-Arm the Immune System

October 14, 2015

The most severe strep infections are often the work of one strain known as M1T1, named for the type of tentacle-like M protein projecting from the bacterium’s surface. Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have uncovered a new way M1 contributes to strep virulence — the protein’s ability to hold off antimicrobial peptides. The study is published October 14 by Cell Host & Microbe.

Breast Cancer Drug Beats Superbug

October 13, 2015

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen MRSA and reduces mortality.
Category navigation with Social links